1. Home
  2. UVV vs SPRY Comparison

UVV vs SPRY Comparison

Compare UVV & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVV
  • SPRY
  • Stock Information
  • Founded
  • UVV 1886
  • SPRY 2015
  • Country
  • UVV United States
  • SPRY United States
  • Employees
  • UVV N/A
  • SPRY N/A
  • Industry
  • UVV Farming/Seeds/Milling
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • UVV Industrials
  • SPRY Health Care
  • Exchange
  • UVV Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • UVV 1.3B
  • SPRY 1.4B
  • IPO Year
  • UVV N/A
  • SPRY N/A
  • Fundamental
  • Price
  • UVV $65.32
  • SPRY $14.43
  • Analyst Decision
  • UVV
  • SPRY Strong Buy
  • Analyst Count
  • UVV 0
  • SPRY 4
  • Target Price
  • UVV N/A
  • SPRY $28.75
  • AVG Volume (30 Days)
  • UVV 220.7K
  • SPRY 1.5M
  • Earning Date
  • UVV 05-29-2025
  • SPRY 05-14-2025
  • Dividend Yield
  • UVV 5.02%
  • SPRY N/A
  • EPS Growth
  • UVV N/A
  • SPRY N/A
  • EPS
  • UVV 3.78
  • SPRY N/A
  • Revenue
  • UVV $2,947,284,000.00
  • SPRY $97,122,000.00
  • Revenue This Year
  • UVV N/A
  • SPRY $1.49
  • Revenue Next Year
  • UVV N/A
  • SPRY $141.68
  • P/E Ratio
  • UVV $17.30
  • SPRY N/A
  • Revenue Growth
  • UVV 7.23
  • SPRY 971120.00
  • 52 Week Low
  • UVV $45.19
  • SPRY $7.55
  • 52 Week High
  • UVV $67.33
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • UVV 79.23
  • SPRY 53.24
  • Support Level
  • UVV $58.68
  • SPRY $14.32
  • Resistance Level
  • UVV $60.19
  • SPRY $15.50
  • Average True Range (ATR)
  • UVV 1.63
  • SPRY 0.84
  • MACD
  • UVV 0.46
  • SPRY 0.12
  • Stochastic Oscillator
  • UVV 83.95
  • SPRY 72.21

About UVV Universal Corporation

Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: